1. Home
  2. SYRE vs NATL Comparison

SYRE vs NATL Comparison

Compare SYRE & NATL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Spyre Therapeutics Inc.

SYRE

Spyre Therapeutics Inc.

HOLD

Current Price

$40.36

Market Cap

2.6B

Sector

Health Care

ML Signal

HOLD

Logo NCR Atleos Corporation

NATL

NCR Atleos Corporation

HOLD

Current Price

$47.98

Market Cap

3.0B

Sector

N/A

ML Signal

HOLD

Company Overview

Basic Information
Metric
SYRE
NATL
Founded
2013
2023
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.6B
3.0B
IPO Year
2015
2023

Fundamental Metrics

Financial Performance
Metric
SYRE
NATL
Price
$40.36
$47.98
Analyst Decision
Strong Buy
Hold
Analyst Count
7
5
Target Price
$55.57
$42.28
AVG Volume (30 Days)
681.3K
978.7K
Earning Date
05-19-2026
06-01-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
73.98
EPS
N/A
2.14
Revenue
N/A
$4,354,000,000.00
Revenue This Year
N/A
$5.99
Revenue Next Year
N/A
$4.53
P/E Ratio
N/A
$22.47
Revenue Growth
N/A
0.86
52 Week Low
$10.91
$22.30
52 Week High
$45.76
$48.40

Technical Indicators

Market Signals
Indicator
SYRE
NATL
Relative Strength Index (RSI) 58.28 76.59
Support Level $14.62 $35.19
Resistance Level $45.76 N/A
Average True Range (ATR) 2.32 1.93
MACD 0.25 0.67
Stochastic Oscillator 58.76 96.28

Price Performance

Historical Comparison
SYRE
NATL

About SYRE Spyre Therapeutics Inc.

Spyre Therapeutics Inc is a biotechnology company that aims to create the next-generation of inflammatory bowel disease (IBD) products by combining antibody engineering, rational therapeutic combinations, and precision medicine approaches for patient selection. IBD is a chronic condition characterized by inflammation within the gastrointestinal tract, including two main disorders which are UC and CD. It has a single reportable segment, which is the development of biopharmaceutical products for the treatment of patients with IBD and other immune-mediated disease.

About NATL NCR Atleos Corporation

NCR Atleos Corp is financial technology company providing self-directed banking solutions to a customer base including financial institutions, merchants, manufacturers, retailers and consumers. Self-directed banking is a rapidly growing, secular trend that allows banking customers to transact seamlessly between various channels all for the same transaction. Their comprehensive solutions enable the acceleration of self-directed banking through ATM and interactive teller machine (ITM) technology, including software, services, hardware and its proprietary Allpoint network. Atleos manage its operations in the following segments which includes Self-Service Banking, Network, and Telecommunications abd Technology.

Share on Social Networks: